About

Sandoz is a global leader in generic pharmaceuticals and biosimilars. We contribute to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs. Our ambition is to be the world’s leading and most valued generics company. Our broad portfolio of high-quality medicines, covering all major therapeutic areas, accounted for 2021 sales of USD 9.6 billion. About Sandoz Sandoz is the leading global provider of off-patent medicines. These generic and biosimilar medicines are more affordable than reference medicines. With a comprehensive portfolio of around 1,500 products covering most major therapeutic areas and available in over 100 countries, we make a real difference for patients and healthcare systems worldwide.